Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RIV Stock Summary
Top 10 Correlated ETFs
RIV
In the News

94 Monthly Paying Dividend Stocks And 80 Funds For March
Imagine stocks or funds that pay out their dividends once a month! Unlike waiting for quarterly, semi-annual or (ugh) annual payouts, your angst waiting for money is reduced by 300%, or more! These March U.S. exchange-traded monthly-paid (MoPay) dividends, upsides, and net-gains include: 1. Stocks by-yield (94); 2. Stocks by price-upside (30); 3. Closed-End-Investments, Exchange-Traded-Funds & Notes (CEICs/ETFs/ETNs) by yield >8.69% (80).

RIV: Unique Strategy And Beats The Market, But Concern About The Distribution
RIV invests in a portfolio of CEFs, BDCs, and other very high-yielding assets to try and give investors an outsized yield. The fund's mix of bonds and common equity would have been an advantage in years past but that is not the case today.

RIV: Modest Returns But 12% Yield Will Lead To Shrinking NAV
The RIV fund tactically invests in CEFs and other funds to exploit inefficiencies. RIV has been relatively successful, with 5Yr average annual total returns of 4.5%.

101 Monthly Paying Dividend Stocks And 80 Funds For January
Imagine stocks or funds that pay-out their dividends once-a-month! Unlike waiting for quarterly, semi-annual or (ugh) annual payouts, your angst waiting for money is reduced by 300%, or more! These January U.S. exchange-traded monthly-paid (MoPay) dividends, upsides, and net-gains include: 1. Stocks by-yield (101); 2. Stocks by price-upside (30); 3. Closed-End-Investments, Exchange-Traded-Funds & Notes (CEICs/ETFs/ETNs) by-yield >8.69% (80).

Weekly Closed-End Fund Roundup: DEX Will Merge With AGD, Tender Next January (December 11, 2022)
2 out of 23 CEF sectors positive on price and 4 out of 23 sectors positive on NAV last week. DEX will merge with AGD.

RIV: Nice Yield But Questions About Sustainability
RiverNorth Opportunities Fund, Inc. is fairly unique among closed-end funds as it invests primarily in SPACs, BDCs, and other funds. The fund is reasonably well-balanced between common equity and fixed income, which should provide a balance between safety and return potential.

Weekly Closed-End Fund Roundup: Special Distributions Coming Up (December 4, 2022)
22 out of 23 CEF sectors positive on price and 22 out of 23 sectors positive on NAV last week. All sectors were positive last week.

Weekly Closed-End Fund Roundup: Tortoise Tender Results, NCZ Resumes Distributions (November 6, 2022)
12 out of 23 CEF sectors positive on price and 6 out of 23 sectors positive on NAV last week. Tortoise offer tender results.

Weekly Closed-End Fund Roundup: Tortoise Tender Offers Expiring (October 23, 2022)
16 out of 23 CEF sectors positive on price and 12 out of 23 sectors positive on NAV last week. Watch for overvalued CEFs as market volatility rises.

Weekly Closed-End Fund Roundup: BlackRock CEFs Repurchasing Shares (October 16, 2022)
0 out of 23 CEF sectors are positive on price and 0 out of 23 sectors are positive on NAV over the last week. BlackRock CEFs are repurchasing their shares.
RIV Financial details
RIV Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-07-31
Metric | History | 2018-07-31 | 2019-07-31 | 2020-07-31 | 2021-07-31 | 2022-07-31 |
---|---|---|---|---|---|---|
Revenue per share | 0.93 | 1.13 | -0.06 | 3.56 | -1.26 | |
Net income per share | 0.78 | 0.96 | -0.21 | 3.44 | -1.4 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0.01 | 0.02 | 2.07 | 0.02 | |
Book value per share | 18.98 | 17.32 | 14.82 | 17.02 | 27.86 | |
Tangible book value per share | 18.98 | 17.32 | 14.82 | 17.02 | 27.86 | |
Share holders equity per share | 18.98 | 17.32 | 14.82 | 17.02 | 27.86 | |
Interest debt per share | 0.01 | 0.02 | 0.81 | 0 | 0.01 | |
Market cap | 102.47M | 125.12M | 139.07M | 226.47M | 182.19M | |
Enterprise value | 102.47M | 125.07M | 146.4M | 200.68M | 181.96M | |
P/E ratio | 24.4 | 18.11 | -71.54 | 5.29 | -10.43 | |
Price to sales ratio | 20.53 | 15.41 | -229.61 | 5.11 | -11.59 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 1.01 | 1 | 1 | 1.07 | 0.53 | |
PTB ratio | 1.01 | 1 | 1 | 1.07 | 0.53 | |
EV to sales | 20.53 | 15.41 | -241.72 | 4.53 | -11.57 | |
Enterprise value over EBITDA | 24.24 | 17.79 | -78.31 | 4.69 | -10.51 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0.04 | 0.06 | -0.01 | 0.19 | -0.1 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0.05 | 0.12 | 0.17 | 0.14 | 0.12 | |
Debt to assets | 0.05 | 0.11 | 0.15 | 0.13 | 0.11 | |
Net debt to EBITDA | 0 | -0.01 | -3.92 | -0.6 | 0.01 | |
Current ratio | 0 | 0 | 0 | 0 | 0 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.11 | 0.08 | -1.14 | 0.02 | -0.07 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 18.3 | 19.34 | 8.31 | 36.3 | 29.67 | |
ROIC | 0 | 0 | 0 | 0 | 0 | |
Return on tangible assets | 0.04 | 0.05 | -0.01 | 0.18 | -0.05 | |
Graham Net | -0.9 | -1.95 | -2.47 | -0.28 | -3.09 | |
Working capital | 0 | 0 | 0 | 0 | 0 | |
Tangible asset value | 101.62M | 124.66M | 139.17M | 211.71M | 346.44M | |
Net current asset value | -5.28M | -14.79M | -23.78M | -30.45M | -41.2M | |
Invested capital | 0 | 0 | 0.05 | 0 | 0 | |
Average receivables | 396.91K | 789.14K | 749.92K | 1.02M | 2.43M | |
Average payables | 202.03K | 529K | 1.15M | 1.78M | 2.02M | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 45.37 | 43.07 | -326.61 | 12.31 | -78.14 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 8.05 | 8.47 | -1.12 | 29.64 | -4.67 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.04 | 0.06 | -0.01 | 0.2 | -0.05 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2022-07-31 for Q4
Metric | History | 2020-07-31 | 2021-01-31 | 2021-07-31 | 2022-01-31 | 2022-07-31 |
---|---|---|---|---|---|---|
Revenue per share | 0.19 | 0 | 0 | 0 | 0 | |
Net income per share | -1 | 0 | 0 | 0 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0.02 | 0 | 0 | 0 | 0 | |
Book value per share | 14.86 | 0 | 0 | 0 | 0 | |
Tangible book value per share | 14.86 | 0 | 0 | 0 | 0 | |
Share holders equity per share | 14.86 | 0 | 0 | 0 | 0 | |
Interest debt per share | -0.24 | 0 | 0 | 0 | 0 | |
Market cap | 138.66M | 0 | 0 | 0 | 0 | |
Enterprise value | 146M | -182.59K | -25.79M | 29.68M | -234.55K | |
P/E ratio | -3.69 | 0 | 0 | 0 | 0 | |
Price to sales ratio | 76.95 | 0 | 0 | 0 | 0 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 1 | 0 | 0 | 0 | 0 | |
PTB ratio | 1 | 0 | 0 | 0 | 0 | |
EV to sales | 81.02 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | -7.64 | 0 | 0 | 0 | 0 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | -0.07 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0.17 | 0.09 | 0.14 | 0.2 | 0.12 | |
Debt to assets | 0.15 | 0.09 | 0.13 | 0.17 | 0.11 | |
Net debt to EBITDA | -0.38 | 0 | 0 | 0 | 0 | |
Current ratio | 0 | 0 | 0 | 0 | 0 | |
Interest coverage | -0.03 | 0 | 0 | 0 | 0 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.04 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 18.31 | 0 | 0 | 0 | 0 | |
ROIC | 0 | 0 | 0 | 0 | 0 | |
Return on tangible assets | -0.06 | 0 | 0 | 0 | 0 | |
Graham Net | -2.48 | 0 | 0 | 0 | 0 | |
Working capital | 0 | 0 | 0 | 0 | 0 | |
Tangible asset value | 139.17M | 167.35M | 211.71M | 280.03M | 346.44M | |
Net current asset value | -23.78M | -15.61M | -30.45M | -56.27M | -41.2M | |
Invested capital | 0.05 | 0 | 0 | 0.11 | 0 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 27.07 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 118.18 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 3.32 | 0 | 0 | 0 | 0 | |
Payables turnover | 0.76 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | -0.07 | 0 | 0 | 0 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
RIV Frequently Asked Questions
What is RiverNorth Opportunities Fund, Inc. stock symbol ?
RiverNorth Opportunities Fund, Inc. is a US stock , located in Chicago of Il and trading under the symbol RIV
What is RiverNorth Opportunities Fund, Inc. stock quote today ?
RiverNorth Opportunities Fund, Inc. stock price is $11.05 today.
Is RiverNorth Opportunities Fund, Inc. stock public?
Yes, RiverNorth Opportunities Fund, Inc. is a publicly traded company.